Experimental research for tumor VIP receptor imaging

您当前的位置：

首页 >

文章列表页 >

Experimental research for tumor VIP receptor imaging

更新时间：2021-04-09

- Experimental research for tumor VIP receptor imaging
- NUCLEAR TECHNIQUES Issue 11, (1998)
- 作者机构：
  
  华西医科大学附属第一医院,610041
- 作者简介：
- 基金信息：
- DOI：
  CLC： R730.4
- Published：01 November 1998
- 稿件说明：
移动端阅览
[1]李前伟,谭天秩.肿瘤VIP受体显像的实验研究[J].核技术,1998(11):641-644.

Experimental research for tumor VIP receptor imaging[J]. Nuclear techniques, 1998, (11): 641-644.
[1]李前伟,谭天秩.肿瘤VIP受体显像的实验研究[J].核技术,1998(11):641-644. DOI：

Experimental research for tumor VIP receptor imaging[J]. Nuclear techniques, 1998, (11): 641-644. DOI：

摘要

探讨了放射性碘标记血管活性肠肽（VIP）实现肿瘤VIP受体显像的可能性。应用氯胺-T法标记、SephadexG－50柱层析分离纯化制备125I－VIP，硅胶TLC与体外竞争结合实验检测标记VIP的稳定性与生物活性；研究125I－VIP在荷SGC7901裸鼠体内分布。结果显示：125I标记率为73．8％；标记VIP的比活度为18．2PBq／mol；放化纯为98％，-80℃贮存48天后为96．3％；VIP以剂量依赖方式抑制125I-VIP与SGC7901细胞结合；各时相肿瘤放射性均高于肌肉（P＜0.05—0.01），高峰摄取时间为30min（3．58±0．48％ID／g），T／N峰比值（3.05）出现于60min；肺放射性高于血液（P＜0．05），肠道放射性始终处于低水平；体内放射性主要经肾脏排泄。本研究表明放射性核素标记VIP可望成为一有效的肿瘤VIP受体显像剂。

Abstract

To study the possibility of radioactive labelled vasoactive intestinal peptiede （VIP） for tumor VIP receptor imaging. 125I-VIP was prepared by chloramine-T method

and purified by sephadex G-50 column chromatography. The bioactivity and stability of 125I-VIP were measured by silica 60 F254 TLC and competition test to SGC7901 cell in vitro. The biodistribution of 125I-VIP was studied in the nude mice bearing tumor. The results showed that labelled rate of 125I was 73.8%

the specific activity was 18.2PBq/mol

the radiochemical purity（RCP） was over 98% and remained 96.3% after 48 days stored at m80oC. The specific binding of 125I-VIP to the SGC7901 cell was inhibited by VIP in dose dependence in the competition experiment. The radioactivity of tumor was higher than that of muscles in all phases （P<0.05-0.01）

the peak activity of tumor occured at 30min （3.58 ± 0.48ID%/g） and the peak ratio of T/N occured at 60min after the injection. The activity of lungs was obviously higher than that of blood

the intestine was always in low level. Most of the activity in the body was mainly eliminated from kidney. The present study demonstrated that the radioactive labelled VIP is a promosing agent for tumor VIP receptor scintigraphy.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Preparation of ¹³¹I-23-hydroxybetulinic acid and in vivo evaluations in liver cancer HepA tumor-bearing mice

Synthesis and biological property evaluation of ⁹⁰Y radiolabeled glycosylated somatostatin

Labeling and animal study of fluorine-18-Levofloxacin

Progress of the targeted tumor therapy with α-emitting nuclides

Preparation of 3H-23-hydroxylbetulinic acid and in vivo evaluations in mice

Related Author

YANG Min1 WANG Guangji2 XU Yuping1 PAN Donghui1 WANG Songpei1 LI Xiaomin1 TANG Jie1 LUO Shineng1 1

王广基

徐宇平

潘栋辉

王颂佩

罗世能

唐婕

李晓敏

Related Institution

中国药科大学

Jiangsu Institute of Nuclear Medicine, Key Laboratory of Nuclear Medicine, Ministry of Health, Wuxi 214063, China) 2

Department of Biophysics, School of Basic Medical Science, Peking University, Beijing 100083) 2

中国原子能科学研究院同位素研究所

北京大学基础医学院生物物理系

AI问答

Address：2019 Jialuo Road, Jiading, Shanghai, China Postal code：201800
Tel：021-39194977 Email：LHB@sinap.ac.cn
Technical support is provided by Beijing Founder electronics co., LTD 沪ICP备05005479号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
Total Visits：880840 Visits Today：367

⁰